E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum β-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 915-919

  Perilli, Mariagrazia ^a   Celenza, Giuseppe ^a   De Santis, Francesca ^a   Pellegrini, Cristina ^a   Forcella, Chiara ^a   Rossolini, Gian Maria ^b   Stefani, Stefania ^c   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM; BETA LACTAMASE; BETA LACTAMASE TEM 149; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; PENICILLIN G; SULBACTAM; TAZOBACTAM; THREONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; ENTEROBACTER AEROGENES; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME STABILITY; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERRATIA MARCESCENS;

EID: 40549097345     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01028-07     Document Type: Article

References (27)

1. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
2. Bradford, P. A. 2001. Extended-spectrum ß-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933–951.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39: 1211–1233.
4. Cantu, C., III, W. Huang, and T. Palzkill. 1996. Selection and characterization of amino acid substitutions at residues 237–240 of TEM-1 ß-lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 37: 22538–22545.
5. Cantu, C., III, W. Huang, and T. Palzkill. 1997. Cephalosporin substrate specificity determinants of TEM-1 ß-lactamase. J. Biol. Chem. 272: 29144– 29150.
6. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Daikos, G. L., C. Kosmidis, P. T. Tassios, G. Petrikkos, A. Vasilakopoulou, M. Psychogiou, I. Stefanou, A. Avlami, and N. Katsilambros. 2007. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob. Agents Chemother. 51: 2366–2372.
8. Farzaneh, S., E. B. Chaibi, J. Peduzzi, M. Barthélémy, R. Labia, J. Blazquez, and F. Baquero. 1996. Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) ß-lactamase. Antimicrob. Agents Chemother. 40: 2434–2436.
9. Gruteke, P., W. Goessens, J. van Gils, P. Peerbooms, N. Lemmens-den Toom, M. van Santen-Verheuvel, A. van Belkum, and H. Verbrugh. 2003. Patterns of resistance associated with integrons, the extended-spectrum ß-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41: 1161–1166.
10. Huang, W., and T. Palzkill. 1997. A natural polymorphism in ß-lactamase is a global suppressor. Proc. Natl. Acad. Sci. USA 94: 8801–8806.
11. Huletsky, A., J. R. Knox, and C. Levesque. 1993. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type ß-lactamases probed by site-directed mutagenesis and three-dimensional modelling. J. Biol. Chem. 268: 3690–3697.
12. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type ß-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39: 2593–2601.
13. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (London) 227: 680–685.
14. Luzzaro, F., M. Mezzatesta, C. Mugnaioli, M. Perilli, S. Stefani, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2006. Trends in production of extended-spectrum ß-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J. Clin. Microbiol. 44: 1659–1664.
15. Orencia, M. C., J. S. Yoon, J. E. Ness, W. P. Stemmer, and R. C. Stevens. 2001. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat. Struct. Biol. 8: 238–242.
16. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum ß-lactamases: a clinical update. Clin. Microbiol. Rev. 18: 657–686.
17. Perilli, M., E. Dell’Amico, B. Segatore, M. R. De Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum ß-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40: 611–614.
18. Perilli, M., G. Celenza, M. Fiore, B. Segatore, C. Pellegrini, F. Luzzaro, G. M. Rossolini, and G. Amicosante. 2007. Biochemical analysis of TEM- 134, a new TEM-type extended-spectrum ß-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital. J. Antimicrob. Chemother. 60: 877–880.
19. Raquet, X., J. Lamotte-Brasseur, E. Fonzé, S. Goussard, P. Courvalin, and J. M. Frére. 1994. TEM ß-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis. J. Mol. Biol. 244: 625–639.
20. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Segel, I. H. 1975. Rapid equilibrium partial and mixed-type inhibition, p. 210–212. In Enzyme kinetics, behavior and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley & Sons, Inc., New York, NY.
22. Shah, P. M., and W. Stille. 1983. Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. J. Antimicrob. Chemother. 11: 597–598.
23. Sideraki, V., W. Huang, T. Palzkill, and H. Gilbert. 2001. A secondary drug resistance mutation of TEM-1 ß-lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. USA 98: 283–288.
24. Steffan, N. H., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using a polymerase chain reaction. Gene 77: 51–59.
25. Stürenburg, E., and D. Mack. 2003. Extended-spectrum ß-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J. Infect. 47: 273–295.
26. Venkatachalam, K. V., W. Huang, M. LaRocco, and T. Palzkill. 1994. Characterization of TEM-1 ß-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazime. J. Biol. Chem. 23: 23444–23450.
27. Wang, X., G. Minasov, and B. K. Shoichet. 2002. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J. Mol. Biol. 320: 85–95.